The role of income disparities on survival in metastatic clear cell renal cell carcinoma in the targeted therapy era.
Yawen ZhengYilun SunHongyan YangJie LiuLigang XingYuping SunPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2020)
In the targeted therapy era, there were survival gaps of mRCC between patients with low- and high-income. Measures should be taken to develop a comprehensive and financially sustainable plan of cancer treatment for greater equity.